Development and Characterization of Apremilast Transethosomal Gel for Transdermal Delivery
DOI:
https://doi.org/10.37285/ijpsn.2021.14.3.8Abstract
The apremilast is anti-inflammatory drug and PDE-4 inhibitor, used in treatment of psoriasis. The oral route of apremilast has limitation of GI irritation and frequent dosage regimen.The objective of the present work was aimed to prepare transethosomal gel of apremilast to achieve more skin permeation, more drug entrapment efficiency and sustained release. The transethosome vesicle containing apremilast was prepared by using Rotary vacuum evaporator, followed by probe sonication. The Box-Behnken design was used to optimize the formulation by taking quantity of lipoid S 100, sodium cholate and ethanol as independent variable and vesicle size, entrapment efficiency and cumulative drug release as dependent variable. The optimized batch of transethosome vesicle was incorporated in 1 % of Carbopol gel base. The prepared optimized batch was evaluated for size, zeta potential, surface morphology, pH, viscosity, spreadability, extrudability, drug content and ex-vivo permeation studies. The result showed that optimized batch of transethosome was found to have vesicle size of 130.8 nm, entrapment efficiency of 62.83 % and cumulative drug release of gel 73.13 %. The transethosome vesicles were found to be spherical and uniform in size based on TEM analysis. The ex-vivo permeation studies were performed for 24 hrs through the rat skin. The formulation was found to show better skin permeation and sustained release. The formulation showed satisfactory result with respect to pH, gel characteristics and stability. Thus, can concluded that transethosomal gel containing apremilast could be an effective option for treatment of psoriasis.
Downloads
Metrics
Keywords:
Apremilast, transethosome, topical drug delivery, gel
Downloads
Published
How to Cite
Issue
Section
References
Abdelgawad R, Nasr M, Hamza MY and Awad GA (2016). Topical and systemic dermal carriers for psoriasis. Int J Curr Pharm Res 8(1): 4-9.
Abdulbaqi IM, Darwis Y, AbouAssi R and Khan NA (2018). Transethosomal gels as carriers for the transdermal delivery of colchicine: statistical optimization, characterization, and ex vivo evaluation. Drug design, development and therapy 12: 795.
Afra TP, Razmi TM and Dogra S (2019). Apremilast in psoriasis and beyond: Big hopes on a small molecule. Indian Dermatology Online Journal 10(1): 1.
Albash R, Abdelbary AA, Refai H, El-Nabarawi MA (2019). Use of transethosomes for enhancing the transdermal delivery of olmesartanmedoxomil: in vitro, ex vivo, and in vivo evaluation. International Journal of Nanomedicine 14: 1953.
Arora S, Lamba HS and Tiwari R (2014). Dermal delivery of drugs using different vesicular carriers: A comparative review. Asian Journal of Pharmaceutics (AJP): Free full text articles from Asian J Pharm 6(4).
Ascenso A, Raposo S, Batista C, Cardoso P, Mendes T, Praça FG, Bentley MV and Simoes S (2015). Development, characteri-zation, and skin delivery studies of related ultradeformable-vesicles: transfersomes, ethosomes, and transethosomes. International Journal of Nanomedicine 10: 5837.
Bhatt P, Fnu G, Bhatia D, Shahid A and Sutariya V (2020). Nanodelivery of Resveratrol-Loaded PLGA nanoparticles for age-related macular degeneration. AAPS PharmaSciTech 21(8): 1-9.
Bhatt P, Lalani R, Vhora I, Patil S, Amrutiya J, Misra A and Mashru R (2018). Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation. International Journal of Pharmaceutics 536: 95-107.
Bhatt P, Narvekar P, Lalani R, Chougule MB, Pathak Y and Sutariya V (2019). An in-vitro assessment of thermo-reversible gel formulation containing sunitinib nanoparticles for neovascular age-related macular degeneration. AAPS Pharma Sci Tech 20(7): 281.
Charles C (2004). Handbook of psoriasis, 2nd ed. John Wiley & Sons, Blackwell publishing.
Garg V, Singh H, Bhatia A, Raza K, Singh SK, Singh B and Beg S (2017). Systematic development of transethosomal gel system of piroxicam: formulation optimization, in vitro evaluation, and ex vivo assessment. AAPS pharmscitech 18(1): 58-71.
Javia A, Amrutiya J, Lalani R, Patel V, Bhatt P and Misra A (2018). Antimicrobial peptide delivery: An emerging therapeutics for the treatment of burns and wounds. Therapeutic Delivery 9(5): 375-386.
Kumar A, Pathak K and Bali V (2012). Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents. Drug Discovery Today 17(21-22): 1233-41.
Lalani R, Misra A, Amrutiya J, Patel H, Bhatt P and Patel V (2017). Challenges in dermal delivery of therapeutics antimicrobial protein and peptides. Current Drug Metabolism 18(5): 426-436.
Lalit Kumar and Utreja P (2019). Formulation and Characterization of Transethosomes for Enhanced Transdermal Delivery of Propranolol Hydrochloride. Micro and Nanosystems, Bentham Science Publishers 11(2):1-10.
Menter A and Griffiths CE (2007). Current and future management of psoriasis. The Lancet 370(9583): 272-284.
Moolakkadath T, Aqil M, Ahad A, Imam SS, Iqbal B, Sultana Y, Mujeeb M and Iqbal Z (2018). Development of transethosomes formulation for dermal fisetin delivery: Box–Behnken design, optimization, in vitro skin penetration, vesicles–skin interaction and dermatokinetic studies. Artificial cells, Nanomedicine, and Biotechnology 46(sup2): 755-65.
Pradhan M, Alexander A, Singh MR, Singh D and Saraf S (2018). Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomedicine & Pharmacotherapy 107: 447-63.
Schafer PH, Parton A, Capone L, Cedzik D, Brady H, Evans JF, Man HW, Muller GW, Stirling DI and Chopra R (2014). Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity. Cellular Signaling 26(9): 2016-29.
Shaji J, Bajaj R (2018). Transethosomes: A New Prospect for Enhanced Transdermal Delivery. International Journal of Pharmaceutical Sciences and Research 9(7): 2681-5.
Shaji J and Bajaj R (2017). Formulation Development of 5-Fluorouracil Transethosomes for Skin Cancer Therapy. IJPPR, Human Journals 11(1): 453-464.
Shaji J and Garude SH (2014). Transethosomes and ethosomes for enhance d transdermal delivery of ketorolac tromethamine: a comparative assessment. Int J Curr Pharm Res 6(4): 88-93.
Sheikh AA, Ali SS, Siddiqui AR, Zahir Z and Ahmad A (2011). Formulation development and characterization of aceclofenac gel containing linseed oil and ginger oleoresin. International Journal of Pharm Tech Research 3(3): 1448-53.
Song CK, Balakrishnan P, Shim CK, Chung SJ, Chong S and Kim DD (2012). A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids and surfaces B: biointerfaces 92: 299-304.
Vats A and Sharma P (2012). Formulation and evaluation of topical anti acne formulation of coriander oil. Int. J. Pharmacy and Pharmaceutical Science Research 2(3): 61-66.
Yewale C, Baradia D, Patil S, Bhatt P, Amrutiya J, Gandhi R and Kore G (2018). Docetaxel loaded immunonanoparticles delivery in EGFR overexpressed breast carcinoma cells. Journal of Drug Delivery Science and Technology 45: 334-345.
